1. Home
  2. GLPG vs RDW Comparison

GLPG vs RDW Comparison

Compare GLPG & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • RDW
  • Stock Information
  • Founded
  • GLPG 1999
  • RDW 2020
  • Country
  • GLPG Belgium
  • RDW United States
  • Employees
  • GLPG N/A
  • RDW N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • RDW Military/Government/Technical
  • Sector
  • GLPG Health Care
  • RDW Industrials
  • Exchange
  • GLPG Nasdaq
  • RDW Nasdaq
  • Market Cap
  • GLPG 1.8B
  • RDW 1.5B
  • IPO Year
  • GLPG 2005
  • RDW N/A
  • Fundamental
  • Price
  • GLPG $24.77
  • RDW $8.56
  • Analyst Decision
  • GLPG Sell
  • RDW Strong Buy
  • Analyst Count
  • GLPG 5
  • RDW 6
  • Target Price
  • GLPG $26.75
  • RDW $17.71
  • AVG Volume (30 Days)
  • GLPG 159.3K
  • RDW 2.0M
  • Earning Date
  • GLPG 04-23-2025
  • RDW 03-10-2025
  • Dividend Yield
  • GLPG N/A
  • RDW N/A
  • EPS Growth
  • GLPG N/A
  • RDW N/A
  • EPS
  • GLPG 1.16
  • RDW N/A
  • Revenue
  • GLPG $285,380,474.00
  • RDW $304,101,000.00
  • Revenue This Year
  • GLPG $0.08
  • RDW $50.01
  • Revenue Next Year
  • GLPG $0.23
  • RDW $37.06
  • P/E Ratio
  • GLPG $21.58
  • RDW N/A
  • Revenue Growth
  • GLPG 14.99
  • RDW 24.73
  • 52 Week Low
  • GLPG $22.36
  • RDW $3.39
  • 52 Week High
  • GLPG $32.17
  • RDW $26.66
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 38.92
  • RDW 30.43
  • Support Level
  • GLPG $24.48
  • RDW $9.22
  • Resistance Level
  • GLPG $25.72
  • RDW $12.18
  • Average True Range (ATR)
  • GLPG 0.51
  • RDW 0.80
  • MACD
  • GLPG -0.15
  • RDW 0.01
  • Stochastic Oscillator
  • GLPG 14.15
  • RDW 13.19

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's Heritage plus Innovation strategy enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

Share on Social Networks: